These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 17913523

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients.
    Barjesteh van Waalwijk van Doorn-Khosrovani S, Erpelinck C, van Putten WL, Valk PJ, van der Poel-van de Luytgaarde S, Hack R, Slater R, Smit EM, Beverloo HB, Verhoef G, Verdonck LF, Ossenkoppele GJ, Sonneveld P, de Greef GE, Löwenberg B, Delwel R.
    Blood; 2003 Feb 01; 101(3):837-45. PubMed ID: 12393383
    [Abstract] [Full Text] [Related]

  • 23. EVI1 induces myelodysplastic syndrome in mice.
    Buonamici S, Li D, Chi Y, Zhao R, Wang X, Brace L, Ni H, Saunthararajah Y, Nucifora G.
    J Clin Invest; 2004 Sep 01; 114(5):713-9. PubMed ID: 15343390
    [Abstract] [Full Text] [Related]

  • 24. The oncogene EVI1 enhances transcriptional and biological responses of human myeloid cells to all-trans retinoic acid.
    Steinmetz B, Hackl H, Slabáková E, Schwarzinger I, Smějová M, Spittler A, Arbesu I, Shehata M, Souček K, Wieser R.
    Cell Cycle; 2014 Sep 01; 13(18):2931-43. PubMed ID: 25486480
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Ecotropic viral integration site 1, a novel oncogene in prostate cancer.
    Queisser A, Hagedorn S, Wang H, Schaefer T, Konantz M, Alavi S, Deng M, Vogel W, von Mässenhausen A, Kristiansen G, Duensing S, Kirfel J, Lengerke C, Perner S.
    Oncogene; 2017 Mar 01; 36(11):1573-1584. PubMed ID: 27617580
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Low expression of MDS1-EVI1-like-1 (MEL1) and EVI1-like-1 (EL1) genes in favorable-risk acute myeloid leukemia.
    Barjesteh van Waalwijk van Doorn-Khosrovani S, Erpelinck C, Löwenberg B, Delwel R.
    Exp Hematol; 2003 Nov 01; 31(11):1066-72. PubMed ID: 14585371
    [Abstract] [Full Text] [Related]

  • 31. Prdm3 and Prdm16 cooperatively maintain hematopoiesis and clonogenic potential.
    McGlynn KA, Sun R, Vonica A, Rudzinskas S, Zhang Y, Perkins AS.
    Exp Hematol; 2020 May 01; 85():20-32.e3. PubMed ID: 32437910
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Aberrant EVI1 splicing contributes to EVI1-rearranged leukemia.
    Tanaka A, Nakano TA, Nomura M, Yamazaki H, Bewersdorf JP, Mulet-Lazaro R, Hogg S, Liu B, Penson A, Yokoyama A, Zang W, Havermans M, Koizumi M, Hayashi Y, Cho H, Kanai A, Lee SC, Xiao M, Koike Y, Zhang Y, Fukumoto M, Aoyama Y, Konuma T, Kunimoto H, Inaba T, Nakajima H, Honda H, Kawamoto H, Delwel R, Abdel-Wahab O, Inoue D.
    Blood; 2022 Aug 25; 140(8):875-888. PubMed ID: 35709354
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The increased expression of integrin α6 (ITGA6) enhances drug resistance in EVI1(high) leukemia.
    Yamakawa N, Kaneda K, Saito Y, Ichihara E, Morishita K.
    PLoS One; 2012 Aug 25; 7(1):e30706. PubMed ID: 22295105
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.